Harout Semerjian - Nov 11, 2022 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Chief Executive Officer, Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
GLYC
Transactions as of
Nov 11, 2022
Transactions value $
$32,250
Form type
4
Date filed
11/14/2022, 03:13 PM
Previous filing
Jan 25, 2022
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Purchase $32.3K +25K $1.29 25K Nov 11, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.27 to $1.29 per share, with a weighted average purchase price of $1.29 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.